GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Baudax Bio BXRXQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Baudax Bio

Our reporting

We have not reported on Baudax Bio yet.

Next results

11 Nov 2026

Due on 11 Nov 2026. Analysts expect earnings of -270.67 a share on revenue of $500,000.

Past results

Reported against what analysts expected

16 Aug 202312 May 202323 Feb 20238 Nov 202211 Aug 2022
Earnings per share-1.494.91-4.25-15.71-27.67
Forecast-2.045.75-9.76-21.20-50.80
Revenue——$310,000$238,000$300,000
Forecast———$965,000$773,000

Key events

  1. 1 Dec 202240-to-1 reverse split
  2. 16 Feb 202235-to-1 reverse split
  3. 14 Nov 2019Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.